Increasing evidences demonstrate the loss of Bim promotes the occurrence of a variety of cancers, including prostate cancer, and endometrial cancer, suggesting a tumour‐suppressive role in these malignancies.51, 52. The gene discussed is BCL2L11; the disease is prostate carcinoma.